Curia and Carterra Partner on Biologics Symposium to Further Biotechnology Research in the Pacific Northwest

Curia & Carterra Biologics Symposium ALBANY, N.Y. and SALT LAKE CITY, May 09, 2024 (GLOBE NEWSWIRE) — Curia, a leading contract research, development and manufacturing organization and Carterra Inc., the world leader in label-free high throughput antibody and small molecule drug discovery, today announced their partnership in hosting a high-throughput biologics symposium slated for May […]

Hitachi Energy supports long-term operation of largest HVDC-connected wind energy project in U.S.

Multi-year agreement provides service solutions to the SunZia Transmission Project, linking New Mexico’s wind farms to Arizona’s grid, increasing renewable energy to Western States Zurich, Switzerland, May 07, 2024 (GLOBE NEWSWIRE) — Hitachi Energy announced that it has signed a multi-year agreement with Pattern Energy to support its high-voltage direct current (HVDC) technologies for the […]

Anaqua Unveils PATTSY WAVE Version 8 IP Management Software

New release empowers IP professionals with enhanced operational efficiency and functionality BOSTON, May 07, 2024 (GLOBE NEWSWIRE) — Anaqua, the leading provider of innovation and intellectual property (IP) management technology, today announces the launch of PATTSY WAVE Version 8, the latest release of the patent and trademark management software. With this announcement, PATTSY WAVE Version 8 offers a […]

Anaqua présente la version 8 de PATTSY WAVE, son logiciel de gestion de la propriété intellectuelle

Cette nouvelle version permet aux professionnels de la propriété intellectuelle de gagner en efficacité opérationnelle et de bénéficier de fonctionnalités améliorées BOSTON, 07 mai 2024 (GLOBE NEWSWIRE) — Anaqua, leader des technologies de gestion de la propriété intellectuelle (PI) et de l’innovation, lance dès aujourd’hui la version 8 de PATTSY WAVE. Il s’agit de la toute […]

Zenas BioPharma Announces Upsized $200 Million Series C Financing to Advance Mid- and Late-Stage Immunology-Focused Clinical Development Programs

Financing led by SR One, NEA, Norwest Venture Partners, and Delos Capital with significant participation from Enavate Sciences, Longitude Capital, and other new and existing investors Proceeds to support ongoing mid- to late-stage clinical development programs for Company’s lead I&I product candidate, obexelimab WALTHAM, Mass., May 07, 2024 (GLOBE NEWSWIRE) — Zenas BioPharma, a global […]

EMAIL NEWSLETTER

Subscribe to receive inspiration, ideas, and news in your inbox